series-c-plus
Stage
1987
Founded
2
Investors
About
Cytel is a multinational statistical software developer and contract research organization providing clinical trial design and implementation services and statistical software products primarily for the biotech and pharmaceutical development markets. It specializes in adaptive trials, a type of randomized clinical trial that allows modifications of ongoing trials while aiming to preserve statistical validity and integrity.
Explore Cytel's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.